Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer |
☐ |
☒ | ||||
Non-accelerated filer |
☐ (Do not check if a smaller reporting company) |
Smaller reporting company |
||||
Emerging growth company |
Page |
||||
4 |
||||
5 |
||||
6 |
||||
7 |
||||
8 |
||||
9 |
||||
15 |
||||
25 |
||||
26 |
||||
27 |
||||
27 |
||||
27 |
||||
27 |
||||
28 |
||||
29 |
• | our ability to achieve profitability; |
• | our competitive position and the effect of competition in our industry; |
• | our ability to retain and attract new customers; |
• | our ability to penetrate existing markets and develop new markets for our services; |
• | our ability to retain or hire qualified accounting and other personnel; |
• | our ability to successfully integrate acquired businesses; |
• | our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; |
• | our ability to maintain the security and reliability of our systems; |
• | our estimates with regard to our future performance and total potential market opportunity; |
• | our estimates regarding our anticipated results of operations, future revenue, bookings growth, capital requirements and our needs for additional financing; and |
• | our goals and strategies, including those related to revenue and bookings growth. |
March 31, 2021 |
December 31, 2020 |
|||||||
(in thousands, except share and per share data) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable, net of allowance of $ |
||||||||
Prepaid expenses |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Intangible assets, net |
||||||||
Goodwill |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Operating lease liability |
||||||||
Deferred revenue |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Operating lease liability, net of current portion |
||||||||
Other liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
$ |
|||||||
Commitments and contingencies (Note 8 ) |
||||||||
Stockholders’ equity: |
||||||||
Undesignated preferred stock, $ |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Treasury stock, at cost; |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands, except share and per share data) |
||||||||
Revenue: |
||||||||
Subscription and support revenue |
$ | $ | ||||||
Professional services and other revenue |
||||||||
|
|
|
|
|||||
Total revenue |
||||||||
Cost of revenue: |
||||||||
Cost of subscription and support revenue |
||||||||
Cost of professional services and other revenue |
||||||||
|
|
|
|
|||||
Total cost of revenue |
||||||||
|
|
|
|
|||||
Gross profit |
||||||||
Operating expenses: |
||||||||
Research and development |
||||||||
Sales and marketing |
||||||||
General and administrative |
||||||||
Merger-related |
— | |||||||
Other (benefit) expense |
( |
) | — | |||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Income (loss) from operations |
( |
) | ||||||
Other expense, net |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Income (loss) before income taxes |
( |
) | ||||||
Provision for income taxes |
||||||||
|
|
|
|
|||||
Net income (loss) |
$ | $ | ( |
) | ||||
Net income (loss) per share—basic and diluted |
||||||||
Basic |
$ | $ | ( |
) | ||||
Diluted |
$ | $ | ( |
) | ||||
Weighted-average shares—basic and diluted |
||||||||
Basic |
||||||||
Diluted |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Other comprehensive income: |
||||||||
Foreign currency translation adjustments |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Comprehensive income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands, except share data) |
||||||||
Shares of common stock issued |
||||||||
Balance, beginning of period |
||||||||
Issuance of common stock upon exercise of stock options and pursuant to restricted stock units |
||||||||
|
|
|
|
|||||
Balance, end of period |
||||||||
|
|
|
|
|||||
Shares of treasury stock |
||||||||
Balance, beginning of period |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Balance, end of period |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Par value of common stock issued |
||||||||
Balance, beginning of period |
$ | $ | ||||||
Issuance of common stock upon exercise of stock options and pursuant to restricted stock units |
— | |||||||
|
|
|
|
|||||
Balance, end of period |
$ | $ | ||||||
|
|
|
|
|||||
Value of treasury stock |
||||||||
Balance, beginning of period |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Balance, end of period |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Additional paid-in capital |
||||||||
Balance, beginning of period |
$ | $ | ||||||
Issuance of common stock upon exercise of stock options and pursuant to restricted stock units, net of tax |
||||||||
Stock-based compensation expense |
||||||||
|
|
|
|
|||||
Balance, end of period |
$ | $ | ||||||
|
|
|
|
|||||
Accumulated deficit |
||||||||
Balance, beginning of period |
$ | ( |
) | $ | ( |
) | ||
Net income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Balance, end of period |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Accumulated other comprehensive loss |
||||||||
Balance, beginning of period |
$ | ( |
) | $ | ( |
) | ||
Foreign currency translation adjustment |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Balance, end of period |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Total stockholders’ equity |
$ | $ | ||||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Operating activities |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: |
||||||||
Depreciation and amortization |
||||||||
Stock-based compensation |
||||||||
Provision for reserves on accounts receivable |
||||||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
( |
) | ||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||
Other assets |
( |
) | ||||||
Accounts payable |
( |
) | ||||||
Accrued expenses |
( |
) | ( |
) | ||||
Operating leases |
( |
) | ( |
) | ||||
Deferred revenue |
||||||||
|
|
|
|
|||||
Net cash (used in) provided by operating activities |
( |
) | ||||||
Investing activities |
||||||||
Purchases of property and equipment |
( |
) | ( |
) | ||||
Capitalized internal-use software costs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Financing activities |
||||||||
Proceeds from exercise of stock options |
||||||||
Deferred acquisition payments |
( |
) | — | |||||
Proceeds from debt |
||||||||
Other financing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents |
( |
) | ||||||
Cash and cash equivalents at beginning of period |
||||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
|
|
|
|
|||||
Supplemental disclosure of cash flow information |
||||||||
Cash paid for operating lease liabilities |
$ | $ | ||||||
|
|
|
|
Allowance for Credit Losses |
||||
(in thousands) |
||||
Balance as of December 31, 2020 |
$ | |||
Current provision for credit losses |
||||
Write-offs against allowance |
( |
) | ||
Recoveries |
||||
Balance as of March 31, 2021 |
$ | |||
Accounts Receivable, net |
Contract Assets (current) |
Deferred Revenue (current) |
Deferred Revenue (non- current) |
Total Deferred Revenue |
||||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Balance at March 31, 2021 |
March 31, 2021 |
||||||||||||
Description |
Contracted Maturity |
Cost |
Fair Market Value |
|||||||||
Cash |
Demand | $ | $ | |||||||||
Money market funds |
Demand | |||||||||||
Total cash and cash equivalents |
$ | $ | ||||||||||
December 31, 2020 |
||||||||||||
Description |
Contracted Maturity |
Cost |
Fair Market Value |
|||||||||
Cash |
Demand | $ | $ | |||||||||
Money market funds |
Demand | |||||||||||
Total cash and cash equivalents |
$ | $ | ||||||||||
Three Months Ended March 31, |
||||
2021 |
||||
Net income (in thousands) |
$ |
|||
Weighted average shares used in computing basic earnings per share |
||||
Effect of weighted average dilutive stock-based awards |
||||
|
|
|||
Weighted average shares used in computing diluted earnings per share |
||||
Net income per share—basic and diluted |
||||
Basic |
$ |
|||
Diluted |
$ |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Options outstanding |
||||||||
Restricted stock units outstanding |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Weighted-average fair value of options granted during the period |
$ | $ | ||||||
Risk-free interest rate |
% | % | ||||||
Expected volatility |
% | % | ||||||
Expected life (in years) |
||||||||
Expected dividend yield |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Stock-based compensation: |
||||||||
Cost of subscription and support revenue |
$ | $ | ||||||
Cost of professional services and other revenue |
||||||||
Research and development |
||||||||
Sales and marketing |
||||||||
General and administrative |
||||||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
Number of Shares |
Weighted-Average Exercise Price |
Weighted-Average Remaining Contractual Term (In Years) |
Aggregate Intrinsic Value (1) |
|||||||||||||
Outstanding at December 31, 2020 |
$ | |||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | $ | |||||||||||||
Canceled |
( |
) | ||||||||||||||
|
|
|||||||||||||||
Outstanding at March 31, 2021 |
$ | $ | ||||||||||||||
|
|
|||||||||||||||
Exercisable at March 31, 2021 |
$ | $ | ||||||||||||||
|
|
(1) | The aggregate intrinsic value was calculated based on the positive difference between the fair value of the Company’s common stock on March 31, 2021 of $ |
S-RSU Shares |
Weighted Average Grant Date Fair Value |
P-RSU Shares |
Weighted Average Grant Date Fair Value |
Total RSU Shares |
Weighted Average Grant Date Fair Value |
|||||||||||||||||||
Unvested at December 31, 2020 |
$ | $ | $ | |||||||||||||||||||||
Granted |
— | — | ||||||||||||||||||||||
Vested and issued |
( |
) | — | — | ( |
) | ||||||||||||||||||
Canceled |
( |
) | — | — | ( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Unvested at March 31, 2021 |
$ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Revenue: |
||||||||
North America |
$ | $ | ||||||
Europe |
||||||||
Japan |
||||||||
Asia Pacific |
||||||||
Other |
||||||||
Total revenue |
$ | $ | ||||||
ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Customers (at period end) |
||||||||
Premium |
2,273 | 2,293 | ||||||
Volume |
1,039 | 1,205 | ||||||
|
|
|
|
|||||
Total customers (at period end) |
3,312 | 3,498 | ||||||
|
|
|
|
|||||
Recurring dollar retention rate |
85 | % | 88 | % | ||||
Average annual subscription revenue per premium customer, excluding Starter edition customers (in thousands) |
$ | 97.0 | $ | 84.6 | ||||
Average annual subscription revenue per premium customer for Starter edition customers only (in thousands) |
$ | 4.3 | $ | 4.5 | ||||
Total backlog, excluding professional services engagements (in millions) |
$ | 147.6 | $ | 125.5 | ||||
Total backlog to be recognized over next 12 months, excluding professional services engagements (in millions) |
$ | 117.1 | $ | 100.5 |
• | Number of Customers month-to-month pay-as-you-go month-to-month pay-as-you-go |
• | Recurring Dollar Retention Rate |
• | Average Annual Subscription Revenue Per Premium Customer |
• | Backlog |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands, except share and per share data) |
||||||||
Revenue: |
||||||||
Subscription and support revenue |
$ | 50,839 | $ | 44,658 | ||||
Professional services and other revenue |
3,978 | 1,995 | ||||||
|
|
|
|
|||||
Total revenue |
54,817 | 46,653 | ||||||
Cost of revenue: |
||||||||
Cost of subscription and support revenue |
15,678 | 16,748 | ||||||
Cost of professional services and other revenue |
3,490 | 1,894 | ||||||
|
|
|
|
|||||
Total cost of revenue |
19,168 | 18,642 | ||||||
|
|
|
|
|||||
Gross profit |
35,649 | 28,011 | ||||||
Operating expenses: |
||||||||
Research and development |
8,284 | 8,853 | ||||||
Sales and marketing |
16,149 | 14,174 | ||||||
General and administrative |
7,059 | 6,532 | ||||||
Merger-related |
— | 5,509 | ||||||
Other (benefit) expense |
(1,965 | ) | — | |||||
|
|
|
|
|||||
Total operating expenses |
29,527 | 35,068 | ||||||
|
|
|
|
|||||
Income (loss) from operations |
6,122 | (7,057 | ) | |||||
Other expense, net |
(735 | ) | (468 | ) | ||||
|
|
|
|
|||||
Income (loss) before income taxes |
5,387 | (7,525 | ) | |||||
Provision for income taxes |
257 | 328 | ||||||
|
|
|
|
|||||
Net income (loss) |
$ | 5,130 | $ | (7,853 | ) | |||
Net income (loss) per share—basic and diluted |
||||||||
Basic |
$ | 0.13 | $ | (0.20 | ) | |||
Diluted |
$ | 0.12 | $ | (0.20 | ) | |||
Weighted-average shares—basic and diluted |
||||||||
Basic |
40,154,035 | 38,981,140 | ||||||
Diluted |
42,480,121 | 38,981,140 |
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Revenue by Product Line |
Amount |
Percentage of Revenue |
Amount |
Percentage of Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
Premium |
$ | 54,022 | 99 | % | $ | 45,787 | 98 | % | $ | 8,235 | 18 | % | ||||||||||||
Volume |
795 | 1 | 866 | 2 | (71 | ) | (8 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 54,817 | 100 | % | $ | 46,653 | 100 | % | $ | 8,164 | 18 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Revenue by Type |
Amount |
Percentage of Revenue |
Amount |
Percentage of Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
Subscription and support |
$ | 50,839 | 93 | % | $ | 44,658 | 96 | % | $ | 6,181 | 14 | % | ||||||||||||
Professional services and other |
3,978 | 7 | 1,995 | 4 | 1,983 | 99 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 54,817 | 100 | % | $ | 46,653 | 100 | % | $ | 8,164 | 18 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Revenue by Geography |
Amount |
Percentage of Revenue |
Amount |
Percentage of Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
North America |
$ | 30,386 | 56 | % | $ | 24,999 | 54 | % | $ | 5,387 | 22 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Europe |
8,923 | 16 | 8,461 | 18 | 462 | 5 | ||||||||||||||||||
Japan |
7,708 | 14 | 6,102 | 13 | 1,606 | 26 | ||||||||||||||||||
Asia Pacific |
7,659 | 14 | 6,870 | 15 | 789 | 11 | ||||||||||||||||||
Other |
141 | — | 221 | — | (80 | ) | (36 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
International subtotal |
24,431 | 44 | 21,654 | 46 | 2,777 | 13 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 54,817 | 100 | % | $ | 46,653 | 100 | % | $ | 8,164 | 18 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Cost of Revenue |
Amount |
Percentage of Related Revenue |
Amount |
Percentage of Related Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
Subscription and support |
$ | 15,678 | 31 | % | $ | 16,748 | 38 | % | $ | (1,070 | ) | (6 | )% | |||||||||||
Professional services and other |
3,490 | 88 | 1,894 | 95 | 1,596 | 84 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 19,168 | 35 | % | $ | 18,642 | 40 | % | $ | 526 | 3 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Gross Profit |
Amount |
Percentage of Related Revenue |
Amount |
Percentage of Related Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
Subscription and support |
$ | 35,161 | 69 | % | $ | 27,910 | 62 | % | $ | 7,251 | 26 | % | ||||||||||||
Professional services and other |
488 | 12 | 101 | 5 | 387 | 383 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 35,649 | 65 | % | $ | 28,011 | 60 | % | $ | 7,638 | 27 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||||||||||||||||
2021 |
2020 |
Change |
||||||||||||||||||||||
Operating Expenses |
Amount |
Percentage of Revenue |
Amount |
Percentage of Revenue |
Amount |
% |
||||||||||||||||||
(in thousands, except percentages) | ||||||||||||||||||||||||
Research and development |
$ | 8,284 | 15 | % | $ | 8,853 | 19 | % | $ | (569 | ) | (6 | )% | |||||||||||
Sales and marketing |
16,149 | 29 | 14,174 | 30 | 1,975 | 14 | ||||||||||||||||||
General and administrative |
7,059 | 13 | 6,532 | 14 | 527 | 8 | ||||||||||||||||||
Merger-related |
— | — | 5,509 | 12 | (5,509 | ) | (100 | ) | ||||||||||||||||
Other (benefit) expense |
(1,965 | ) | (4 | ) | — | — | (1,965 | ) | N/A | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 29,527 | 54 | % | $ | 35,068 | 75 | % | $ | (5,541 | ) | (16 | )% | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
Condensed Consolidated Statements of Cash Flow Data |
2021 |
2020 |
||||||
(in thousands) | ||||||||
Cash flows (used in) provided by operating activities |
$ | (604 | ) | $ | 2,441 | |||
Cash flows used in investing activities |
$ | (1,522 | ) | $ | (2,693 | ) | ||
Cash flows provided by financing activities |
$ | 533 | $ | 10,010 |
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK (in thousands, except share and per share data, unless otherwise noted)Quantitative and Qualitative Disclosures about Market Risk |
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Revenues generated in locations outside the United States |
48 | % | 51 | % | ||||
Revenues in currencies other than the United States dollar (1) |
29 | % | 31 | % | ||||
Expenses in currencies other than the United States dollar (1) |
17 | % | 16 | % |
(1) | Percentage of revenues and expenses denominated in foreign currency for the three months ended March 31, 2021 and 2020: |
Three Months Ended March 31, 2021 |
Three Months Ended March 31, 2020 |
|||||||||||||||
Revenues |
Expenses |
Revenues |
Expenses |
|||||||||||||
Euro |
7 | % | 0 | % | 8 | % | 1 | % | ||||||||
British pound |
6 | 6 | 6 | 6 | ||||||||||||
Japanese Yen |
14 | 3 | 13 | 2 | ||||||||||||
Other |
2 | 8 | 4 | 7 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
29 | % | 17 | % | 31 | % | 16 | % |
ITEM 4. |
CONTROLS AND PROCEDURES |
ITEM 1. |
LEGAL PROCEEDINGS |
ITEM 1A. |
RISK FACTORS |
ITEM 5. |
OTHER INFORMATION |
ITEM 6. |
EXHIBITS |
Exhibits |
||
3.1 (1) | Eleventh Amended and Restated Certificate of Incorporation. | |
3.2 (2) | Amended and Restated By-Laws. | |
4.1 (3) | Form of Common Stock certificate of the Registrant. | |
10.1† | Amendment No. 2 to the 2012 Stock Incentive Plan. | |
31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1^ | Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101.INS | XBRL Instance Document. | |
101.SCH | XBRL Taxonomy Extension Schema Document. | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | |
104* | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) |
(1) | Filed as Exhibit 3.2 to Amendment No. 5 to Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on February 6, 2012, and incorporated herein by reference. |
(2) | Filed as Exhibit 3.3 to Amendment No. 5 to Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on February 6, 2012, and incorporated herein by reference. |
(3) | Filed as Exhibit 4.1 to Amendment No. 5 to Registrant’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on February 6, 2012, and incorporated herein by reference. |
^ | Furnished herewith. |
† | Indicates a management contract or any compensatory plan, contract or arrangement. |
BRIGHTCOVE INC. | ||||||
(Registrant) | ||||||
Date: April 28, 2021 | By: | |||||
/s/ Jeff Ray | ||||||
Jeff Ray | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) |
Date: April 28, 2021 | By: |
|||||
/s/ Robert Noreck | ||||||
Robert Noreck | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |